Search
Find a recruiting study
7,114 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Oct 28, 2026). No sign-up needed.
Most recently updated studies · page 93 of 297
- Recruiting
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Kaneka Medical America LLC
- Location
- Loma Linda, CA + 9 other US sites
- Eligibility basics
- Up to age 21
- Recruiting
Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
Kaneka Medical America LLC
- Location
- Loma Linda, CA + 9 other US sites
- Eligibility basics
- Up to age 75
- RecruitingPhase 2/Phase 3
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Merck Sharp & Dohme LLC
- Location
- Los Angeles, CA + 19 other US sites
- Eligibility basics
- Ages 1 mo–17
- RecruitingPhase 1/Phase 2
Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
Skyline Therapeutics (US) Inc.
- Location
- Boston, MA + 2 other US sites
- Eligibility basics
- Ages 50+
- Recruiting
MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors
Clinical Nutrition Research Center, Illinois Institute of Technology
- Location
- Chicago, IL
- Eligibility basics
- Ages 40–60
- RecruitingEarly Phase 1
Examining the Effects of Theta Burst TMS on Brain Connectivity and Balance Ability in Older Adults With Balance Problems
Weinberg Medical Physics LLC
- Location
- Houston, TX
- Eligibility basics
- Ages 65+
- RecruitingPhase 1/Phase 2
ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy
Alexion Pharmaceuticals, Inc.
- Location
- Birmingham, AL + 6 other US sites
- Eligibility basics
- Ages 18–70
- Recruiting
Pivotal Trial to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (The TRINITY Pivotal Trial)
Jenscare Innovation Inc.
- Location
- Naples, FL + 1 other US site
- Eligibility basics
- Ages 21+
- RecruitingPhase 2
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Apollo Therapeutics Ltd
- Location
- Birmingham, AL + 24 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
DreaMed Diabetes
- Location
- Detroit, MI + 4 other US sites
- Eligibility basics
- Ages 18–80
- Recruiting
A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
Salvia BioElectronics
- Location
- Newnan, GA + 2 other US sites
- Eligibility basics
- Ages 22–84
- RecruitingPhase 3
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
CSL Behring
- Location
- San Diego, CA + 3 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Nipro Vascular Innovations Americas, Inc
- Location
- Scottsdale, AZ + 16 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Cytokinetics
- Location
- Fairhope, AL + 23 other US sites
- Eligibility basics
- Ages 40–85
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
UCB Biopharma SRL
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
A Study of VV-14305 for the Treatment of Thyroid Eye Disease
Kriya Therapeutics, Inc.
- Location
- Livonia, MI + 2 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 1/Phase 2
Open-label Study of SKY-GJB2 in Pediatric Subjects With GJB2-mediated Hearing Loss
Skylark Bio Inc.
- Location
- Bethesda, MD + 3 other US sites
- Eligibility basics
- Ages 10 mo–7
- RecruitingPhase 3
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
Harmony Biosciences Management, Inc.
- Location
- Peoria, AZ + 26 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers
Merakris Therapeutics
- Location
- Tucson, AZ + 9 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
Locate Bio Pty Ltd
- Location
- Fort Wayne, IN + 2 other US sites
- Eligibility basics
- Ages 22–80
- Recruiting
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
i-Lumen Scientific AUS PTY LTD
- Location
- Poway, CA + 5 other US sites
- Eligibility basics
- Ages 60+
- RecruitingPhase 2
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
R1 Therapeutics
- Location
- Huntsville, AL + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy and Safety of Novosis Putty in Transforaminal Lumbar Interbody Fusion for Patients With Lumbar Degenerative Disc Disease
CGBio Inc.
- Location
- Little Rock, AR + 7 other US sites
- Eligibility basics
- Ages 21–80
- Recruiting
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
EmStop Inc
- Location
- Thousand Oaks, CA + 6 other US sites
- Eligibility basics
- Ages 22+
Data source: daily sync of the ClinicalTrials.gov API. How we list studies